: Determining where the therapeutic gene goes in the body and how long it persists in both target and non-target cells.
: Defining scientific principles for non-clinical studies specifically for gene therapies, which differ significantly from conventional pharmaceuticals. Key Safety Requirements : 125459
The number most commonly refers to a specific scientific guideline established by the European Medicines Agency (EMA) regarding the development of Gene Therapy Medicinal Products (GTMPs) . : Determining where the therapeutic gene goes in
: Checking if the patient might "shed" or spread the virus/vector through secretions. : Checking if the patient might "shed" or
Guideline on the Non-Clinical Studies Required before First ... - EMA
: This guideline is a cornerstone for developers of Advanced Therapy Medicinal Products (ATMPs) in the European Union.
For more detailed technical specifications, you can access the full Guideline on Non-Clinical Studies for GTMPs via the official .